Janney Montgomery Scott
BRNS

Janney Montgomery Scott’s Barinthus Biotherapeutics BRNS Stock Holding History

Janney Montgomery Scott’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,373
Closed -$19K – 2922
2025
Q3 		$19K Hold
15,373
– – ﹤0.01% 2845
2025
Q2 		$14K Hold
15,373
– – ﹤0.01% 2691
2025
Q1 		$15K Buy
15,373
+365
+2% +$375 ﹤0.01% 2652
2024
Q4 		$18K Hold
15,008
– – ﹤0.01% 2671
2024
Q3 		$18K Hold
15,008
– – ﹤0.01% 2636
2024
Q2 		$21K Hold
15,008
– – ﹤0.01% 2582
2024
Q1 		$36K Hold
15,008
– – ﹤0.01% 2689
2023
Q4 		$55K Hold
15,008
– – ﹤0.01% 2580
2023
Q3 		$46K Buy
+15,008
New +$32.3K ﹤0.01% 2520

Other funds holding BRNS

HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JHU
Johns Hopkins University Baltimore, Maryland $1.38B AUM 9.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Janney Montgomery Scott's BRNS Position: Q4 2025 in Review

Janney Montgomery Scott sold out of Barinthus Biotherapeutics (BRNS) in Q4 2025, closing a stake of 15,373 shares — an estimated $19K sold.

Janney Montgomery Scott first reported a position in BRNS in Q3 2023 and held it in 9 quarters. The position peaked at $55K in Q4 2023. 13 funds tracked by Wall St. Rank hold BRNS as of Q4 2025.

  • Janney Montgomery Scott reported no remaining Barinthus Biotherapeutics position as of Q4 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 15,373 Barinthus Biotherapeutics shares in Q4 2025, an estimated $19K.
  • Janney Montgomery Scott first reported a position in Barinthus Biotherapeutics in Q3 2023 and held it in 9 quarters.
  • Janney Montgomery Scott's Barinthus Biotherapeutics position peaked at $55K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Barinthus Biotherapeutics as of Q4 2025.

Based on Janney Montgomery Scott's 13F filing for Q4 2025, filed 11 Feb 2026.